Literature DB >> 3311112

Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas.

P Dias1, P Kumar, H B Marsden, P H Morris-Jones, J Birch, R Swindell, S Kumar.   

Abstract

The diagnostic and prognostic relevance of desmin expression in 80 rhabdomyosarcomas (RMS) and 5 embryonal sarcomas (ES) was examined using a peroxidase anti-peroxidase staining procedure. Fifty-nine RMS but only one ES stained for desmin (P less than 0.05). The maximum percentage of desmin containing cells was 49 in RMS compared with only 1% in ES. Desmin positivity correlated inversely with survival (P less than 0.02) in that RMS with high proportions of desmin positive cells were associated with poorer prognoses than those containing fewer desmin positive cells. If the degree of expression of desmin is related to myogenic differentiation, then our results indicate that poorly differentiated RMS tend to have a better prognosis than the well differentiated tumours. One possible explanation is that the poorly differentiated RMS respond better to chemotherapy than to well differentiated RMS. A multivariant analysis incorporating desmin staining, treatment, histology, age and gender revealed that the two most significant independent prognostic factors were treatment and histology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311112      PMCID: PMC2002207          DOI: 10.1038/bjc.1987.203

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Creatine kinase subunits M and B as markers in the diagnosis of poorly differentiated rhabdomyosarcomas in children.

Authors:  A S de Jong; M van Kessel-van Vark; C E Albus-Lutter; P A Voûte
Journal:  Hum Pathol       Date:  1985-09       Impact factor: 3.466

2.  Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy.

Authors:  W M Molenaar; J W Oosterhuis; W A Kamps
Journal:  Hum Pathol       Date:  1984-10       Impact factor: 3.466

Review 3.  Advances in the care of the child with cancer. The importance of histologic subclassification of tumors.

Authors:  B E Favara; C A Galliani; P E Wakely
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

4.  Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas.

Authors:  W M Molenaar; J W Oosterhuis; A M Oosterhuis; F C Ramaekers
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

5.  Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods.

Authors:  H J Kahn; H Yeger; O Kassim; A O Jorgensen; D H MacLennan; R Baumal; C R Smith; M J Phillips
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

6.  Localization of the B and M polypeptide subunits of creatine kinase in normal and neoplastic human tissues by an immunoperoxidase technic.

Authors:  L E Wold; C Y Li; H A Homburger
Journal:  Am J Clin Pathol       Date:  1981-03       Impact factor: 2.493

7.  Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.

Authors:  M Altmannsberger; K Weber; R Droste; M Osborn
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

8.  Soft-tissue sarcomas in childhood. A study of 262 cases including 169 cases of rhabdomyosarcoma.

Authors:  D Harms; D Schmidt; J Treuner
Journal:  Z Kinderchir       Date:  1985-06

9.  Medulloblastoma. Period of risk reviewed.

Authors:  J P Latchaw; J F Hahn; D J Moylan; R Humphries; J Mealey
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

  9 in total
  8 in total

1.  Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

Authors:  P Dias; D M Parham; D N Shapiro; B L Webber; P J Houghton
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Influence of dimethyl sulphoxide on intermediate filament proteins in human rhabdomyosarcoma cell lines: modulation at subcellular level.

Authors:  C Melguizo; J Prados; C Velez; A E Aranega; L Alvarez; A Aranega
Journal:  Histochem J       Date:  1994-06

3.  Desmin expression in rhabdomyosarcoma: influence of the desmin clone and immunohistochemical method.

Authors:  L Pollock; D Rampling; S E Greenwald; M Malone
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

4.  Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.

Authors:  Yanlei Ma; Jiayuan Peng; Weijie Liu; Peng Zhang; Long Huang; Benbo Gao; Tongyi Shen; Yukun Zhou; Hongqi Chen; Zhaoxin Chu; Ming Zhang; Huanlong Qin
Journal:  Mol Cell Proteomics       Date:  2009-05-20       Impact factor: 5.911

5.  Malignant mesenchymoma of the chest wall in an adult.

Authors:  S K Jain; M Afzal; M Mathew; S K Ramani
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

6.  In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

Authors:  P Nanni; G Azzarello; L Tessarollo; C De Giovanni; P L Lollini; G Nicoletti; K Scotlandi; L Landuzzi; M Panozzo; E D'Andrea
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

7.  Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas.

Authors:  M Leader; J Patel; M Collins; K Henry
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

8.  Proteomics study reveals that the dysregulation of focal adhesion and ribosome contribute to early pregnancy loss.

Authors:  Lingli Xin; Benhong Xu; Li Ma; Qingxiang Hou; Mei Ye; Shu Meng; Xiaoping Ding; Wei Ge
Journal:  Proteomics Clin Appl       Date:  2016-05       Impact factor: 3.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.